Abstract
We investigated how the graft-versus-leukemia (GVL) effect is attenuated in the tumor microenvironment using a murine model of non-myeloablative allo-HSCT (NM-HSCT) plus delayed donor leukocyte infusion (DLI) in a haploidentical B6→F1 strain combination. In-line with aggravated leukemia growth, the proportions of effector T cells expressing IFN-γ (Teffs) in spleen were reduced and attenuated GVL activity was found to be accompanied by a rebound in CD4 +Foxp3 + regulatory T cells (Tregs) in tumor-draining lymph nodes and tumor tissues. DLI-derived Tregs and Teffs may be potential indicators of presence of leukemic progression after DLI in this GVL model.
| Original language | English |
|---|---|
| Pages (from-to) | 1549-1556 |
| Number of pages | 8 |
| Journal | Leukemia Research |
| Volume | 35 |
| Issue number | 12 |
| DOIs | |
| State | Published - Dec 2011 |
Bibliographical note
Funding Information:This study was supported by the Korea Healthcare Technology R&D Project, Ministry of Health, Welfare & Family Affairs , Republic of Korea (grant no. A092258 ).
Keywords
- Allogeneic hematopoietic stem cell transplantation
- Graft-versus-host disease
- Graft-versus-leukemia effect
- Regulatory T cells
- TGF-β